XVIVO Perfusion Lund AB is a biotechnology company based in Lund, Sweden. The organization specializes in the development of innovative technologies for organ preservation and perfusion. Their primary focus is on improving the viability and function of organs for transplantation, which is critical in addressing the shortage of available organs and enhancing transplant outcomes.
The company has developed several proprietary products and techniques aimed at optimizing the preservation of organs during transportation and storage. These advancements are designed to extend the time that organs can remain viable outside the human body, thereby increasing the chances of successful transplantation. XVIVO Perfusion Lund AB collaborates with various research institutions and healthcare providers to further enhance their technologies and contribute to the field of organ transplantation.
In addition to their core products, XVIVO Perfusion Lund AB is involved in ongoing research and development efforts to explore new applications and improve existing methodologies. The company plays a significant role in the biotechnology sector, particularly in the context of transplant medicine, where their innovations aim to save lives and improve patient outcomes.